Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02934529
Title Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab (AIO-KRK-0114)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Ludwig-Maximilians - University of Munich

rectum adenocarcinoma

colorectal cancer

colon adenocarcinoma


Cetuximab + Fluorouracil + Irinotecan + Leucovorin

Bevacizumab + Capecitabine + Fluorouracil + Leucovorin


Age Groups: adult | senior
Covered Countries DEU

Additional content available in CKB BOOST